WO2001070982A2
(fr)
*
|
2000-03-23 |
2001-09-27 |
Immusol Incorporated |
Regulateurs de brca-1 et procedes d'utilisation
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
DE69936382T3
(de)
|
1998-05-15 |
2011-07-07 |
Genentech, Inc., Calif. |
Therapeutische verwendungen von il-17 homologe polypeptide
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
EP1163252A4
(fr)
*
|
1999-02-25 |
2004-04-07 |
Univ Jefferson |
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs
|
EP1157038A4
(fr)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
Clonage du recepteur 7tm (axor 17) du type p2y
|
EP1169440A4
(fr)
*
|
1999-03-23 |
2004-01-14 |
Human Genome Sciences Inc |
48 proteines humaines secretees
|
WO2000058480A1
(fr)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Nouvelle cytidine desaminase
|
EP1621620A3
(fr)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
|
US7083944B1
(en)
*
|
1999-10-27 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Molecules of the card-related protein family and uses thereof
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
EP1878795A3
(fr)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions et procédés pour le traitement de maladies liées au système immunitaire
|
CA2492070A1
(fr)
*
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Polypeptides pro4329 marqueurs de tumeurs du poumon et acides nucleiques codant lesdits polypeptides
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US7510855B2
(en)
|
2000-01-26 |
2009-03-31 |
Agensys, Inc. |
84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
US20020031815A1
(en)
*
|
2000-06-26 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
US20020025931A1
(en)
|
2000-03-24 |
2002-02-28 |
Rachel Meyers |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
CA2407044A1
(fr)
|
2000-04-25 |
2001-11-01 |
Lexicon Genetics Incorporated |
Nouvelles proteines kinases humaines et polynucleotides les codant
|
WO2001081586A2
(fr)
*
|
2000-04-26 |
2001-11-01 |
Millennium Pharmaceuticals, Inc. |
21657, deshydrogenase humaine a chaine courte et ses utilisations
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
CA2408828A1
(fr)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Nouvelle serine-threonine kinase-4
|
EP1158001B1
(fr)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs
|
AU7634301A
(en)
*
|
2000-05-26 |
2001-12-03 |
Bayer Aktiengesellschaft |
Regulation of human p78-like serine/threonine kinase
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2001094385A2
(fr)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Regulation du recepteur couple a la proteine humaine g de type hm74
|
JP2004512023A
(ja)
*
|
2000-06-09 |
2004-04-22 |
コリクサ コーポレイション |
結腸癌の治療および診断のための組成物および方法
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
AU2001268435A1
(en)
*
|
2000-06-15 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
23680, a novel human aminotransferase and uses therefor
|
WO2001096546A2
(fr)
*
|
2000-06-16 |
2001-12-20 |
Incyte Genomics, Inc. |
Proteine-phosphatases
|
CA2648048A1
(fr)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
EP1309684A2
(fr)
*
|
2000-06-27 |
2003-05-14 |
Curagen Corporation |
Polynucleotides et polypeptides codes par ceux-ci
|
WO2002000939A2
(fr)
|
2000-06-28 |
2002-01-03 |
Diadexus, Inc. |
Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
|
AU2001273148A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Millennium Pharmaceuticals, Inc. |
57658, a human uridine kinase and uses thereof
|
WO2002004510A2
(fr)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Proteines liant le nucleotide guanine
|
JP2004513618A
(ja)
*
|
2000-07-07 |
2004-05-13 |
インサイト・ゲノミックス・インコーポレイテッド |
輸送体及びイオンチャネル
|
WO2002006326A2
(fr)
*
|
2000-07-14 |
2002-01-24 |
Millennium Pharmaceuticals, Inc. |
62088, un nouveau membre humain de la famille nucleoside phosphatase, et utilisations de ce dernier
|
AU2001281967A1
(en)
*
|
2000-07-18 |
2002-01-30 |
Bayer Aktiengesellschaft |
Regulation of human desc1-like serine protease
|
WO2002006318A2
(fr)
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Procedes et compositions permettant de stabiliser des microtubules et des filaments intermediaires dans des cellules de muscle strie
|
CA2416456A1
(fr)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
AU8762901A
(en)
*
|
2000-07-25 |
2002-02-05 |
Merck Patent Gmbh |
Novel protein containing ring finger domaine r1p4
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
WO2002008281A2
(fr)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Proteine bstp-cad et reactifs associes et methodes d'utilisation
|
EP1657254A3
(fr)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
WO2002010217A2
(fr)
|
2000-08-02 |
2002-02-07 |
The Johns Hopkins University |
Profils d'expression de cellules endotheliales
|
EP1315431A1
(fr)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
US6924364B2
(en)
|
2000-08-04 |
2005-08-02 |
Zymogenetics, Inc. |
Human secreted protein, Zzp1
|
AU2001281252A1
(en)
|
2000-08-10 |
2002-02-18 |
Board Of Regents, The University Of Texas System |
The tumor suppressor car-1
|
AU9174501A
(en)
*
|
2000-08-11 |
2002-02-25 |
Merck Patent Gmbh |
Novel mitogen activated kinase
|
EP1326985A1
(fr)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification d'un gene d'acetyltransferase n-terminale humaine
|
AU2001285109A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Incyte Genomics, Inc. |
Microtubule-associated proteins and tubulins
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
WO2002016579A2
(fr)
*
|
2000-08-24 |
2002-02-28 |
Eli Lilly And Company |
Acides nucleiques, vecteurs, cellules hotes, polypeptides et utilisations de ces derniers
|
CA2420902A1
(fr)
*
|
2000-08-28 |
2002-03-07 |
Craig A. Rosen |
18 proteines humaines secretees
|
AU2001284176A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
EP2022797A3
(fr)
|
2000-08-28 |
2011-11-09 |
Agensys, Inc. |
Acide nucléique et protéine correspondante intitulée 85P1B3 utile dans le traitement et la détection du cancer
|
US20030224396A1
(en)
*
|
2000-08-30 |
2003-12-04 |
Yonghong Xiao |
Regulation of human aminotransferase-like enzyme
|
US20020091238A1
(en)
*
|
2000-08-30 |
2002-07-11 |
Curtis Rory A.J. |
54370, a novel human sulfate transporter and uses therefor
|
US20020146800A1
(en)
*
|
2000-08-30 |
2002-10-10 |
Curtis Rory A.J. |
48921, a novel human GTP releasing factor and uses therefor
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
AU2001288600A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
WO2002020762A2
(fr)
|
2000-09-05 |
2002-03-14 |
Amgen Inc. |
Molecules analogues au recepteur du tnf et ses utilisations
|
CA2421265A1
(fr)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules utilisees a des fins diagnostiques et therapeutiques
|
AU2001288999A1
(en)
*
|
2000-09-08 |
2002-03-22 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
EP1349930A2
(fr)
*
|
2000-10-05 |
2003-10-08 |
Curagen Corporation |
Polypeptides humains, acides nucleiques codant ces deuniers et leurs methodes d'utilisation
|
EP1402010A2
(fr)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
WO2002031143A2
(fr)
*
|
2000-10-12 |
2002-04-18 |
The Texas A & M University System |
Sequences d'acides nucleiques codant des proteines cmg, proteines cmg et leurs procedes d'utilisation
|
EP1474528A4
(fr)
*
|
2000-10-13 |
2006-06-14 |
Protein Design Labs Inc |
Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
JP2004518437A
(ja)
|
2000-10-25 |
2004-06-24 |
ディアデクサス インコーポレーテッド |
肺特異的遺伝子およびタンパク質に関する組成物および方法
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
WO2002040672A2
(fr)
|
2000-11-20 |
2002-05-23 |
Diadexus, Inc. |
Compositions et methodes relatives a des genes et des proteines specifiques aux seins
|
WO2002081667A2
(fr)
*
|
2000-12-05 |
2002-10-17 |
Incyte Genomics, Inc. |
Ligases
|
CA2430379A1
(fr)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Retrovirus endogenes regules positivement dans le cancer de la prostate
|
AU2002226033A1
(en)
|
2000-12-07 |
2002-06-18 |
Zymogenetics Inc. |
Adipocyte complement related protein zacrp3x2
|
CA2439800A1
(fr)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
US6858407B2
(en)
|
2000-12-22 |
2005-02-22 |
Bristol-Myers Squibb Company |
Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2002053591A1
(fr)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
|
AU2002236717A1
(en)
*
|
2001-01-08 |
2002-07-16 |
Lexicon Genetics Incorporated |
Human protease and polynucleotides encoding the same
|
AU2002243750A1
(en)
*
|
2001-01-30 |
2002-08-12 |
Regeneron Pharmaceuticals, Inc. |
Novel nucleic acid and polypeptide molecules
|
WO2002098917A2
(fr)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
|
EP1637601A3
(fr)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
EP1434783A4
(fr)
*
|
2001-03-16 |
2006-06-07 |
Lilly Co Eli |
Proteines de mammiferes lp et reactifs associes
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
AU2002258626B2
(en)
|
2001-04-10 |
2007-01-18 |
Agensys, Inc. |
Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
|
CA2443123A1
(fr)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers
|
ATE512216T1
(de)
|
2001-04-10 |
2011-06-15 |
Agensys Inc |
Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
|
JP2004532030A
(ja)
*
|
2001-04-24 |
2004-10-21 |
イシス・イノベイション・リミテッド |
疾病用酵素とsnpマーカー
|
WO2002088175A1
(fr)
*
|
2001-04-24 |
2002-11-07 |
Otsuka Pharmaceutical Co., Ltd. |
Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie
|
KR100882762B1
(ko)
*
|
2001-05-07 |
2009-02-09 |
시오노기세이야쿠가부시키가이샤 |
혈관신생 마커로서 사용되는 폴리펩티드 및 이의 dna
|
WO2002090543A2
(fr)
*
|
2001-05-09 |
2002-11-14 |
Bayer Aktiengesellschaft |
Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003000901A2
(fr)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Acides nucleiques codant des proteines kinases
|
GB2399087A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ7
|
JP2005504546A
(ja)
*
|
2001-08-17 |
2005-02-17 |
インサイト・ゲノミックス・インコーポレイテッド |
細胞内シグナル伝達分子
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
EP1463806B1
(fr)
|
2001-09-28 |
2011-01-05 |
Brigham Young University |
Nouveaux variants de la cyclooxygenase et methodes d'utilisation
|
WO2003038087A1
(fr)
|
2001-10-04 |
2003-05-08 |
Kansai Technology Licensing Organization Co., Ltd. |
Promoteur du gene dr5 et promoteur du gene siah-1
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003031607A1
(fr)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation de deshydrogenase/reductase des chaines courtes humaine
|
ATE364690T1
(de)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
Posh nukleinsäure, polypeptide und darauf bezogene verfahren
|
US7491690B2
(en)
|
2001-11-14 |
2009-02-17 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
JPWO2003044197A1
(ja)
*
|
2001-11-21 |
2005-03-24 |
独立行政法人科学技術振興機構 |
ハンチントン病遺伝子転写因子
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
AU2002339697A1
(en)
*
|
2001-12-19 |
2003-06-30 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
JP2003245084A
(ja)
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
WO2003060109A2
(fr)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Regulation d'une subtilase humaine
|
WO2003059948A1
(fr)
*
|
2002-01-15 |
2003-07-24 |
Medigene Ag |
Gene-2 associe a la myocardiopathie dilatee (dcmag-2) : inducteur cytoplasmique du remodelage sarcomerique de cardiomyocytes
|
JPWO2003062429A1
(ja)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
新規セリンプロテアーゼ
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
EP1338609A1
(fr)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Un outre récepteur KDR et son utilisation
|
EP1497311A2
(fr)
*
|
2002-03-05 |
2005-01-19 |
Applera Corporation |
Proteines transporteuses humaines isolees, molecules d'acide nucleique codant celles-ci, et utilisations associees
|
AU2003208472A1
(en)
*
|
2002-03-06 |
2003-09-16 |
Oxford Glycosciences (Uk) Ltd |
Novel b-cell malignancy-associated protein
|
DK2258872T3
(da)
|
2002-03-13 |
2013-11-18 |
Genomic Health Inc |
Genekspressionsprofilering i biopsier af tumorvæv
|
JP3949111B2
(ja)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
新規gタンパク質共役型受容体およびその遺伝子
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのdnaおよびその用途
|
AU2003238178A1
(en)
|
2002-05-29 |
2003-12-12 |
Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
WO2003101401A2
(fr)
|
2002-06-03 |
2003-12-11 |
Chiron Corporation |
Utilisation de nrg4, ou d'inhibiteurs de nrg4, dans le traitement du cancer du colon et du pancreas
|
EP1513934B1
(fr)
|
2002-06-06 |
2011-03-02 |
Oncotherapy Science, Inc. |
Genes et polypeptides en rapport avec les cancers du colon chez l'homme
|
AU2003276679A1
(en)
|
2002-06-13 |
2003-12-31 |
Chiron Corporation |
Vectors for expression of hml-2 polypeptides
|
CA2493263A1
(fr)
*
|
2002-07-22 |
2004-01-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveau gene associe a l'arthrite rhumatoide
|
JP4186004B2
(ja)
|
2002-08-14 |
2008-11-26 |
独立行政法人産業技術総合研究所 |
新規n−アセチルガラクトサミン転移酵素およびそれをコードする核酸
|
WO2004016733A2
(fr)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
|
WO2004018518A1
(fr)
*
|
2002-08-23 |
2004-03-04 |
Japan Science And Technology Agency |
Peptides antigeniques de tumeur cancereuse solide humains, polynucleotides codant pour ceux-ci et utilisation de ceux-ci
|
EP1540014A2
(fr)
*
|
2002-08-27 |
2005-06-15 |
Epigenomics AG |
Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
CA2500472A1
(fr)
|
2002-09-30 |
2004-04-15 |
Oncotherapy Science, Inc. |
Genes et polypeptides associes aux cancers du pancreas chez l'homme
|
WO2004035823A2
(fr)
*
|
2002-10-17 |
2004-04-29 |
Evotec Neurosciences Gmbh |
Utilisation diagnostique et therapeutique des gene et proteine ensadin-0625 destinee a des maladies neurodegeneratives
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
EP1570080A4
(fr)
|
2002-11-15 |
2006-03-01 |
Genomic Health Inc |
Etablissement de profils d'expressions genetique du cancer a recepteur de facteur de croissance epidermique positif
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004070025A2
(fr)
*
|
2003-02-05 |
2004-08-19 |
Juan Saus |
Nouvelles isoformes de la proteine liant l'antigene de goodpasture et troubles induits par une proteine incorrectement repliee
|
EP1445614A1
(fr)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu
|
US7074891B2
(en)
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
EP1597391B1
(fr)
|
2003-02-20 |
2008-10-29 |
Genomic Health, Inc. |
Utilisation d'arn intronique pour mesurer l'expression genique
|
US20060142222A1
(en)
*
|
2003-03-04 |
2006-06-29 |
Makoto Ogino |
Novel gene relating to fibrotic conditions
|
EP1606409B1
(fr)
*
|
2003-03-19 |
2010-09-01 |
Biogen Idec MA Inc. |
Proteine de liaison de recepteur de nogo
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
EP3170906B1
(fr)
|
2003-06-24 |
2018-08-22 |
Genomic Health, Inc. |
Prédiction de probabilité de récurrence de cancer
|
WO2005008213A2
(fr)
|
2003-07-10 |
2005-01-27 |
Genomic Health, Inc. |
Algorithme de profile d'expression et test du pronostic du cancer
|
EP1652923B1
(fr)
|
2003-08-08 |
2011-10-12 |
Perseus Proteomics Inc. |
Gene surexprime dans le cancer
|
WO2005018554A2
(fr)
*
|
2003-08-12 |
2005-03-03 |
Washington University In St. Louis |
Proteine de surface cellulaire isolee inductible par la chaleur et therapie d'immunociblage de tumeurs basee sur l'hyperthermie
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
WO2005032584A2
(fr)
*
|
2003-10-02 |
2005-04-14 |
Glaxosmithkline Biologicals S.A. |
Composes
|
MXPA06003686A
(es)
|
2003-10-03 |
2007-03-01 |
Brigham & Womens Hospital |
Ligandos tim-3 y sus metodos.
|
WO2005040791A2
(fr)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr)
|
WO2005051994A2
(fr)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Facteur de necrose tumorale ztnf11
|
ATE541580T1
(de)
|
2003-12-05 |
2012-02-15 |
Univ Northwestern |
Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor
|
WO2005064019A2
(fr)
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Amplification universelle d'arn fragmente
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
ES2537633T3
(es)
|
2004-03-02 |
2015-06-10 |
The Johns Hopkins University |
Mutaciones del gen de PIK3CA en cánceres humanos
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
WO2005090569A1
(fr)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
|
EP2289911A3
(fr)
*
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Utilisation thérapeutique du facteur de croissance nsg33
|
CA2563074C
(fr)
|
2004-04-09 |
2014-05-20 |
Genomic Health, Inc. |
Marqueurs d'expression genique permettant de predire la reponse a la chimiotherapie
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
WO2005118832A2
(fr)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl)
|
JP4960865B2
(ja)
|
2004-06-24 |
2012-06-27 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
脱髄に関連する状態の処置
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
US7985831B2
(en)
*
|
2004-08-05 |
2011-07-26 |
Toagosei Co., Ltd. |
Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease
|
PL1836629T3
(pl)
|
2004-11-05 |
2020-06-15 |
Genomic Health, Inc. |
Przewidywanie odpowiedzi na chemioterapię z zastosowaniem markerów ekspresji genu
|
ATE550440T1
(de)
|
2004-11-05 |
2012-04-15 |
Genomic Health Inc |
Molekulare indikatoren für brustkrebsprognose und vorhersage des ansprechens auf eine behandlung
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
KR101027427B1
(ko)
|
2004-11-12 |
2011-04-11 |
젠코어 인코포레이티드 |
FcRn에 대하여 증가된 결합력을 갖는 Fc 변이체
|
CA2598251A1
(fr)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Epitopes angiogeniques de liaison a l'heparine, amphiphiles peptidiques, compositions auto-assemblees et procedes d'utilisation associes
|
CA2608315C
(fr)
*
|
2005-05-13 |
2014-08-05 |
Centre National De La Recherche Scientifique |
Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
|
KR101245462B1
(ko)
|
2005-07-08 |
2013-03-20 |
바이오겐 아이덱 엠에이 인코포레이티드 |
Sp35 항체 및 그의 용도
|
EP1907589A4
(fr)
*
|
2005-07-26 |
2010-11-24 |
Siemens Healthcare Diagnostics |
Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
|
US8207128B2
(en)
*
|
2005-09-28 |
2012-06-26 |
Supadelixir Inc. |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
JP5236488B2
(ja)
|
2005-12-14 |
2013-07-17 |
ハーモ ファーマ エルテーデー. |
新規な神経栄養因子タンパク質およびその用途
|
WO2008003656A2
(fr)
*
|
2006-07-03 |
2008-01-10 |
Exonhit Therapeutics Sa |
Produits de la transcription spécifiques de la prostate et leur utilisation pour des thérapeutiques et des diagnostics du cancer de la prostate
|
US20080108070A1
(en)
*
|
2006-09-08 |
2008-05-08 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
EP2565204B1
(fr)
|
2007-07-27 |
2015-10-07 |
immatics biotechnologies GmbH |
Nouveaux épitopes immunogènes pour l'immunothérapie
|
US7863021B2
(en)
*
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
WO2009034661A1
(fr)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Procédé de diagnostic et induction d'une résistance à un virus
|
EP2216340B1
(fr)
|
2007-10-17 |
2012-12-12 |
Universidad De Córdoba |
Isoformes du récepteur de la somatostatine humaine de type 5 produites par traitement alternatif et paires d'oligonucléotides permettant de les détecter par pcr
|
SI2235059T1
(sl)
|
2007-12-26 |
2015-06-30 |
Xencor, Inc. |
Fc variante s spremenjeno vezjo na fcrn
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
EP3112379A1
(fr)
*
|
2008-03-21 |
2017-01-04 |
Universiteit Hasselt |
Biomarqueurs pour la polyarthrite rhumatoïde
|
EP2315779A2
(fr)
|
2008-07-09 |
2011-05-04 |
Biogen Idec MA Inc. |
Compositions comprenant des anticorps anti-lingo ou leurs fragments
|
CN102164611B
(zh)
|
2008-07-24 |
2015-01-07 |
Ns基因公司 |
生长因子metrnl的治疗用途
|
SI2172211T1
(sl)
|
2008-10-01 |
2015-03-31 |
Immatics Biotechnologies Gmbh |
Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka
|
AU2009313808B2
(en)
|
2008-11-14 |
2013-05-16 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
CA2745849A1
(fr)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Nouveau variant retroviral endogene humain d'erv3 et utilisations de celui-ci pour diagnostiquer le cancer des ovaires
|
JP2012523463A
(ja)
|
2009-04-13 |
2012-10-04 |
ノースウエスタン ユニバーシティ |
軟骨再生のための新規なペプチドベースの足場およびその使用方法
|
WO2011028952A1
(fr)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions et procédés pour une co-liaison bivalente et monovalente simultanée d'antigènes
|
ES2802623T3
(es)
*
|
2010-01-27 |
2021-01-20 |
Massachusetts Inst Technology |
Agentes polipeptídicos técnicamente diseñados para la neutralización dirigida de amplio espectro de la gripe
|
TW202344270A
(zh)
|
2010-09-29 |
2023-11-16 |
美商艾澤西公司 |
與191p4d12蛋白結合之抗體藥物共軛物(adc)
|
KR101886029B1
(ko)
|
2010-10-01 |
2018-08-07 |
호바 세라퓨틱스 에이피에스 |
무해자극통증, 통각과민증, 자발통증 및 헛통증의 치료를 위한 메테오린의 용도
|
DK2651430T3
(en)
*
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
EP2753347B1
(fr)
|
2011-09-05 |
2016-08-03 |
NsGene A/S |
Traitement de l'allodynie, de l'hyperalgie, de la douleur spontanée et de la douleur illusionnelle
|
WO2013068445A1
(fr)
*
|
2011-11-09 |
2013-05-16 |
Sanofi |
Diacylglycérol lipase et applications associées
|
CN104334573A
(zh)
|
2012-04-30 |
2015-02-04 |
比奥孔有限公司 |
靶向/免疫调节性融合蛋白及其制造方法
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
CN104470541A
(zh)
|
2012-05-14 |
2015-03-25 |
比奥根艾迪克Ma公司 |
用于治疗涉及运动神经元的疾患的lingo-2拮抗剂
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
RU2678127C2
(ru)
|
2012-11-13 |
2019-01-23 |
Бионтех Аг |
Агенты для лечения экспрессирующих клаудин раковых заболеваний
|
WO2014127785A1
(fr)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
US9023353B2
(en)
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
WO2014146672A1
(fr)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
|
KR20210157418A
(ko)
|
2013-03-27 |
2021-12-28 |
세다르스-신나이 메디칼 센터 |
Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
|
EP3971287A1
(fr)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprenant des polynucléotides synthétiques codant pour des protéines liées à crispr et des arnsg synthétiques et méthodes d'utilisation
|
EP4105236A1
(fr)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anticorps contre tl1a (tnfsf15) pour le traitement des maladies inflammatoires de l'intestin
|
EP3049111A2
(fr)
|
2013-09-25 |
2016-08-03 |
Cytomx Therapeutics Inc. |
Substrats pour métalloprotéinases matricielles et autres fragments clivables et leurs procédés d'utilisation
|
JP6558699B2
(ja)
|
2013-10-01 |
2019-08-14 |
国立大学法人三重大学 |
抗原提示を促進するエピトープ間配列を含むt細胞誘導ワクチン
|
CA2937370A1
(fr)
|
2014-01-31 |
2015-08-06 |
Cytomx Therapeutics, Inc. |
Substrats pour matriptase et activateur u-plasminogene et autres fractions clivables, et leurs procedes d'utilisation
|
US10435467B2
(en)
|
2015-01-08 |
2019-10-08 |
Biogen Ma Inc. |
LINGO-1 antagonists and uses for treatment of demyelinating disorders
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
US11124766B2
(en)
*
|
2015-06-12 |
2021-09-21 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
PT3344776T
(pt)
|
2015-09-04 |
2021-08-03 |
Synthetic Genomics Inc |
Microorganismos recombinantes de algas com aumento de produtividade
|
EP3430172A4
(fr)
|
2016-03-17 |
2019-08-21 |
Cedars-Sinai Medical Center |
Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2
|
WO2017172941A2
(fr)
*
|
2016-03-29 |
2017-10-05 |
Berz David |
Modulation de l'entretien structural de l'expression du chromosome-1
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
EP3508499A1
(fr)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations
|
AU2020261435A1
(en)
*
|
2019-04-26 |
2021-11-25 |
Sangamo Therapeutics, Inc. |
Engineering AAV
|
US20220372138A1
(en)
|
2019-07-05 |
2022-11-24 |
Iomx Therapeutics Ag |
Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
|
WO2021083958A1
(fr)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Nouveaux peptides induisant la satiété
|
WO2021228999A1
(fr)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Épitopes néo-antigéniques associés à des mutations sf3b1
|
US20240010720A1
(en)
|
2020-07-06 |
2024-01-11 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
CN117529492A
(zh)
*
|
2021-01-21 |
2024-02-06 |
鹿特丹伊拉斯谟大学医疗中心 |
用于治疗的t细胞
|
JP2024509376A
(ja)
*
|
2021-02-18 |
2024-03-01 |
ベレン セラピューティクス ピー.ビー.シー. |
家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法
|
US20240158457A1
(en)
*
|
2022-05-20 |
2024-05-16 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|